Kenvue (KVUE) Projected to Release Quarterly Earnings on Thursday

Kenvue (NYSE:KVUE) is anticipated to issue its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Kenvue to announce earnings of $0.3188 per share and revenue of $3.9660 billion for the quarter. Individuals may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 6, 2026 at 9:30 AM ET.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm’s revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.24 EPS. On average, analysts expect Kenvue to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Kenvue Price Performance

KVUE stock opened at $19.54 on Wednesday. The stock has a 50-day moving average price of $18.66 and a two-hundred day moving average price of $18.05. Kenvue has a 1 year low of $14.02 and a 1 year high of $22.22. The stock has a market cap of $37.51 billion, a PE ratio of 22.98, a price-to-earnings-growth ratio of 1.44 and a beta of 0.47. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be given a dividend of $0.21 per share. This is an increase from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 annualized dividend and a dividend yield of 4.3%. The ex-dividend date of this dividend is Wednesday, August 12th. Kenvue’s payout ratio is currently 98.82%.

Wall Street Analysts Forecast Growth

KVUE has been the topic of a number of recent research reports. Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Barclays upped their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Citigroup lowered their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Finally, Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a report on Sunday, July 12th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $19.58.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.59% of the company’s stock.

Hedge Funds Weigh In On Kenvue

A number of institutional investors have recently bought and sold shares of the business. B & T Capital Management DBA Alpha Capital Management lifted its position in shares of Kenvue by 0.3% in the fourth quarter. B & T Capital Management DBA Alpha Capital Management now owns 234,664 shares of the company’s stock valued at $4,048,000 after buying an additional 712 shares during the last quarter. Advisory Services Network LLC raised its stake in Kenvue by 2.0% in the 2nd quarter. Advisory Services Network LLC now owns 49,807 shares of the company’s stock valued at $1,068,000 after acquiring an additional 983 shares during the period. CIBC Private Wealth Group LLC lifted its holdings in Kenvue by 20.1% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 6,388 shares of the company’s stock valued at $104,000 after purchasing an additional 1,068 shares during the last quarter. Wilmington Savings Fund Society FSB boosted its position in Kenvue by 4.0% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 28,877 shares of the company’s stock worth $498,000 after purchasing an additional 1,107 shares during the period. Finally, Port Capital LLC increased its holdings in shares of Kenvue by 10.6% in the third quarter. Port Capital LLC now owns 15,994 shares of the company’s stock valued at $260,000 after purchasing an additional 1,537 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.